Technology digest: non-viral vectors

References

• 1. Bio-Techne. Cell therapy and gene therapy manufacturing workflow _ Bio-Techne. www.bio-techne.com/research-areas/cell-and-gene-therapy
  Google Scholar
• 2. Hu C, Li L. Current reprogramming systems in regenerative medicine: from somatic cells to induced pluripotent stem cells. Regen. Med. 11(1), 91–105 (2016).
  CASGoogle Scholar
• 3. Frommolt R, Rohrbach F, Theobald M. Sleeping Beauty transposon system – future trend in T-cell-based gene therapies? Future Oncol. 2(3), 345–349 (2006).
  CASGoogle Scholar
• 4. Amberger M, Ivics Z. Latest advances for the sleeping beauty transposon system: 23 years of insomnia but prettier than ever. BioEssays 42, 2000136 (2020).
  Google Scholar
• 5. Bio-Techne. Gene engineering services _ Bio-Techne. www.bio-techne.com/services/gene-engineering-services
  Google Scholar
• 6. Robbins GM, Wang M, Pomeroy EJ, Moriarity BS. Nonviral genome engineering of natural killer cells. Stem Cell Res. Ther. 12, 1–9 (2021).
  MedlineGoogle Scholar
• 7. Pomeroy EJ, Lahr WS, Change LW et al. Non-viral engineering of CAR-NK and CAR-T cells using the TcBuster transposon system™. doi: 10.1101/2021.08.02.454772
  Google Scholar
• 8. Patrinostro Z, Jones B, Barnes B, Zarecki Hermanson D, Otto N. An enhanced TcBuster™ (TcB-M™) transposase has been developed for highly efficient and robust delivery of therapeutic cargo for both RUO and clinical applications. American Society of Gene & Cell Therapy. DC, USA (2022).
  Google Scholar
• 9. Tipanee J, Chai YK, VandenDriessche T, Chuah MK. Preclinical and clinical advances in transposon-based gene therapy. Biosci. Rep. 22, 37(6), BSR20160614 (2017).
  MedlineGoogle Scholar
• 10. Tipanee J, VandenDriessche T, Chuah MK. Transposons: moving forward from preclinical studies to clinical trials. Hum. Gene Ther. 28(11), 1087–1104 (2017).
  Medline CASGoogle Scholar
• 11. Sainz-Ramos M, Gallego I, Villate-Beitia I et al. How far are non-viral vectors to come of age and reach clinical translation in gene therapy? Int. J. Mol. Sci. 22(14), 7545 (2021).
  Medline CASGoogle Scholar